结论:新生儿呼吸窘迫综合症注意呼吸道管理。
Conclusion: Neonatal respiratory distress syndrome respiratory tract attention.
目的评价肺表面活性物质 (PS)替代治疗新生儿呼吸窘迫综合症 (NRDS )的疗效及安全性。
Objective To evaluate the efficacy and safety of pulmonary surfactant(PS)in the replacement therapy for neonatal respiratory distress syndrome(NRDS).
新生儿中最常见的临床表现是呼吸窘迫综合症,其次是早产、败血症(均为41%)和肝脾肿大(13%)。
The most common presentations in neonates were respiratory distress syndrome, followed by preterm birth and signs of sepsis (both 41%) and hepatosplenomegaly (13%).
新生儿中最常见的临床表现是呼吸窘迫综合症,其次是早产、败血症(均为41%)和肝脾肿大(13%)。
The most common presentations in neonates were respiratory distress syndrome, followed by preterm birth and signs of sepsis (both 41%) and hepatosplenomegaly (13%).
应用推荐